Sergey Alexeev


About

I am an economist–statistician specialising in trial-based and quasi-experimental evaluation, predictive modelling, and cost–benefit analysis. I work with linked administrative and clinical datasets to answer policy questions across health, labour, housing, and criminal justice, and I build reproducible pipelines in R/Stata/Python/SQL for secure data environments—an approach reinforced through my work as a contributor to the Institute for Replication (I4R).

I am currently a Senior Research Associate at UNSW’s Nura Gili Centre for Indigenous Programs, and an Adjunct Senior Lecturer at the University of Sydney’s NHMRC Clinical Trials Centre. I serve on the Editorial Board of the International Journal of Drug Policy, and I’m a member of the NSW Population & Health Services Research Ethics Committee (PHSREC).

Sergey Alexeev

UNSW profile · CV · Research / Teaching statements · Google Scholar · ORCID · ResearchGate · X · LinkedIn

Mentorship

I’m actively looking for HDR/PhD candidates and collaborators. My work spans econometrics, biostatistics, epidemiology, and health economics, and I work closely with applied partners on decision-facing questions. I also do expert witness / independent expert reports for courts and tribunals, which keeps me grounded in what “decision-ready” evidence looks like: clear assumptions, transparent methods, careful interpretation, and outputs that stand up to scrutiny. As a result, I regularly come across concrete, high-impact projects that can be shaped into publishable theses.

If you’re interested, email me at sergei.v.alexeev@gmail.com with a short note about your background and interests, or message me on WhatsApp at +61 457 871 540. You’re also welcome to reach out to my current and past students for candid feedback on my supervision style (e.g., Alexandra Gallagher, Jessica Cornish, and Oscar Ninou).

Quick rule of thumb

Publications

Journal articles & related media coverage

Other writing

Consulting

I help organisations answer high-stakes, decision-facing questions with evidence that is transparent, defensible, and usable. My consulting work combines economics, biostatistics, and health economics to evaluate policies, programs, and technologies — from causal impact evaluation (trial-based and quasi-experimental) to economic evaluation (cost-effectiveness, cost–benefit, budget impact) and clear decision briefs for non-technical audiences.

My background spans corporate finance and project delivery (Russia/France), economics (Canada), and a PhD in economics, and I now apply that toolkit in Australian public health and policy. Practically, that means I scope quickly, agree on the decision, comparators and assumptions up front, build a workable data strategy, and deliver decision-ready outputs (including reproducible code where appropriate). I’m comfortable working in secure data environments (including PLIDA) and maintain current HILDA access, so projects can move from question → analysis → defensible write-up without hand-waving.

I also produce expert witness / independent expert reports for courts and tribunals, which keeps me grounded in what “stands up to scrutiny”: clear logic, transparent methods, careful interpretation, and sensitivity analysis that makes uncertainty explicit. Selected engagements include expert witness work for the Fair Work Commission (AM2024/20; instructed by Piper Alderman) and the Industrial Relations Commission of NSW (2025/187709), advisory input for Deloitte and Rennie Advisory, and cross-agency evaluation work with NSW Justice Health, Corrective Services NSW, and BOCSAR.

If you’d like to discuss a project, email me at with a few lines on the decision you need to make, your timeline, and what data you have (or can access). I’ll reply with a simple scope and options.

Grants

Teaching

Details: Teaching page